No Result

View All Result

No products in the cart.

Home Tag esophageal squamous cell carcinoma

Tag: esophageal squamous cell carcinoma

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

byMeagan Wiedermanand1 others

September 16, 2021

1. Camrelizumab improved the overall survival and the progression-free survival of esophageal squamous cell carcinoma patients compared to placebo treatment ...

#VisualAbstract: Trastuzumab emtansine monotherapy is noninferior to standard neoadjuvant therapy for ERBB2+ breast cancer

#VisualAbstract: Concurrent S-1-based chemoradiotherapy improves survival compared to radiotherapy alone in older patients with esophageal cancer

byTeddy Guo

September 9, 2021

Click to read the study in JAMA Oncology.

#VisualAbstract: Induction chemotherapy does not improve survival for patients receiving chemoradiotherapy for esophageal squamous cell carcinoma

byTeddy Guo

August 11, 2021

Click to read the study in Nature Communications.

#VisualAbstract: Metformin use is associated with a decreased risk of basal cell carcinoma

#VisualAbstract: Pembrolizumab plus cetuximab shows early clinical efficacy for patients with recurrent or metastatic head and neck squamous cell carcinoma

byTeddy Guo

July 15, 2021

Click to read the study in The Lancet Oncology.

Ipilimumab plus anti-PD-1 therapy is effiective in patients with anti-PD-L1 resistant metastatic melanoma

#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

byTeddy Guo

July 8, 2021

Click to read the study in the Journal of Clinical Oncology.

Neoadjuvant chemoradiotherapy plus surgery increases overall survival of patients with advanced esophageal squamous cell carcinoma compared to surgery alone

byMeagan Wiedermanand1 others

June 28, 2021

1. Neoadjuvant chemoradiotherapy (NCRT) with surgery improves the death rate, overall survival, disease-free survival time, and locoregional and distal recurrence ...

#VisualAbstract: Docetaxel, cisplatin, and cetuximab regimen is a safe alternative for patients with squamous cell carcinoma of the head and neck

byTeddy Guo

May 27, 2021

Click to read the study in The Lancet Oncology.

#VisualAbstract: Pembrolizumab improves long-term survival in patients with stage III melanoma

#VisualAbstract: Avelumab does not improve outcomes in patients receiving chemoradiotherapy for squamous cell carcinomas of the head and neck

byTeddy Guo

May 6, 2021

Click to read the study in The Lancet Oncology.

#VisualAbstract: Liver metastases and LDH levels may be superior prognostic biomarkers for patients with metastatic melanoma

#VisualAbstract: No differences in survival in patients with esophageal cancer treated with neoadjuvant chemotherapy or chemoradiotherapy followed by esophagectomy

byTeddy Guo

April 22, 2021

Click to read the study in JAMA Surgery.

#VisualAbstract: Local excision margins greater than 1 cm and receipt of radiotherapy are associated with improved overall survival in Merkel cell carcinoma

#VisualAbstract: Major postoperative complications are associated with worse long-term survival in patients undergoing esophagectomy

byTeddy Guo

June 19, 2021

Click to read the study in JAMA Surgery.

Page 2 of 3 Prev 1 2 3 Next

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: esophageal squamous cell carcinoma

Camrelizumab with chemotherapy demonstrated improved overall survival and progression-free survival of esophageal squamous cell carcinoma patients versus placebo

#VisualAbstract: Concurrent S-1-based chemoradiotherapy improves survival compared to radiotherapy alone in older patients with esophageal cancer

#VisualAbstract: Induction chemotherapy does not improve survival for patients receiving chemoradiotherapy for esophageal squamous cell carcinoma

#VisualAbstract: Pembrolizumab plus cetuximab shows early clinical efficacy for patients with recurrent or metastatic head and neck squamous cell carcinoma

#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

Neoadjuvant chemoradiotherapy plus surgery increases overall survival of patients with advanced esophageal squamous cell carcinoma compared to surgery alone

#VisualAbstract: Docetaxel, cisplatin, and cetuximab regimen is a safe alternative for patients with squamous cell carcinoma of the head and neck

#VisualAbstract: Avelumab does not improve outcomes in patients receiving chemoradiotherapy for squamous cell carcinomas of the head and neck

#VisualAbstract: No differences in survival in patients with esophageal cancer treated with neoadjuvant chemotherapy or chemoradiotherapy followed by esophagectomy

#VisualAbstract: Major postoperative complications are associated with worse long-term survival in patients undergoing esophagectomy

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits